Postmenopausal hormone therapy and risk of venous thromboembolism: what about progesterone?
BMJ
.
2019 Feb 11:364:l601.
doi: 10.1136/bmj.l601.
Author
Pierre-Yves Scarabin
1
Affiliation
1
Inserm U1018, Hôpital Paul Brousse, 94807 Villejuif, France.
PMID:
30745295
DOI:
10.1136/bmj.l601
No abstract available
Publication types
Letter
Comment
MeSH terms
Case-Control Studies
Estrogen Replacement Therapy
Hormone Replacement Therapy
Humans
Postmenopause
Progesterone*
Venous Thromboembolism*
Substances
Progesterone